Therapeutic effects of combined oxaliplatin and S-1 in older patients with advanced gastric cardiac adenocarcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

310

HTML

2089

Tables (1-6)

172

Sum=2571

Dec 21, 2011 (publication date) through Jul 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 21, 2011; 17(47): 5221-5226
Published online Dec 21, 2011. doi: 10.3748/wjg.v17.i47.5221

Table 3 Comparisons of chemotherapy sensitivity, case (%)

^aχ² = 0.062, P = 0.804 vs control group. CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease.

Citation: Gao SG, Jia RN, Feng XS, Xie XH, Shan TY, Pan LX, Song NS, Wang YF, Ding KL, Wang LD. Therapeutic effects of combined oxaliplatin and S-1 in older patients with advanced gastric cardiac adenocarcinoma. World J Gastroenterol 2011; 17(47): 5221-5226
URL: https://www.wjgnet.com/1007-9327/full/v17/i47/5221.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i47.5221